Search

Contrast nephropathy is a major concern of interventional cardiologists caring for renally vulnerable patients. It can result in a spectrum of complications, ranging from prolonged hospitalization, to permanent degradation of renal function, to dialysis, and even to death. Furthermore, the threat of

The paper by Marenzi et al. ([1][1]) in JACC: Cardiovascular Interventions on prevention of contrast-induced nephropathy (CIN) using furosemide with matched hydration deals with a pertinent and pervasive problem. In this randomized trial of 170 patients who received contrast media during coronary